© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, CVS Health Corporation (CVS) shows an Average True Range (ATR) of 1.89 and an Enterprise Value of 156.47B. Its average trading volume over the past 3 months is 7.13M, indicating liquidity. These fundamental metrics provide insight into CVS's underlying financial health and market activity.
CVS Health Corporation (CVS) technical indicators as of December 22, 2025: the SMA 20 is -0.62%, SMA 50 at -1.66%, and SMA 200 at 10.42%. The RSI 14 value is 47.81, suggesting its current momentum. These technical analysis signals help assess CVS's price trends and potential future movements.
CVS Health Corporation (CVS) stock performance overview as of December 22, 2025: The 52-week high is $85.15 (currently -8.73% below), and the 52-week low is $43.56 (currently 78.42% above). Over the past year, CVS's performance is 57.42%, compared to the S&P 500's 12.87% change.
According to market data, CVS Health Corporation (CVS) stock's recent performance metrics show that over the last month, CVS is -0.28%, with a Year-to-Date (YTD) performance of 73.13%. Over the past year, the stock has seen a 57.42% change. These figures summarize CVS's price movements across various periods, reflecting its historical returns.
According to current financial data, CVS stock's P/E (TTM) ratio is 210.29, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CVS, including P/S (0.25), P/B (1.35), and P/FCF (15.68), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.